Related Experiment Video
Updated: Jun 8, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Renal complications in transfusion-dependent beta thalassaemia
Claudio Ponticelli1, Khaled M Musallam, Paolo Cianciulli
1Division of Nephrology, Humanitas Scientific Institute, Milan, Italy. claudio.ponticelli@fastwebnet.it
Patients with beta thalassaemia major (TM) may experience kidney problems due to iron overload or treatment. These renal changes often resolve or require dose adjustments, but long-term outcomes need further study.
Area of Science:
- Nephrology
- Hematology
- Pediatric Medicine
Background:
- Increased survival in beta thalassaemia major (TM) patients has led to the manifestation of various morbidities.
- Renal manifestations in TM patients, including tubular dysfunction and glomerular filtration rate abnormalities, are poorly understood, particularly long-term outcomes.
- Existing evidence primarily comes from pediatric studies, highlighting a need for prospective investigation in adult populations.
Purpose of the Study:
- To evaluate the renal manifestations associated with beta thalassaemia major and its treatment.
- To investigate the long-term outcomes of kidney function changes in TM patients.
- To understand the underlying mechanisms and sequelae of renal abnormalities in TM.
Main Methods:
- Review of existing evidence on renal function in pediatric TM patients.
- Analysis of potential contributing factors: iron overload, iron chelation therapy, and underlying anemia.
- Discussion of the nonprogressive nature and spontaneous resolution of observed renal changes.
Main Results:
- Evidence suggests tubular dysfunction and abnormal glomerular filtration rates in TM patients.
- Renal changes appear to be largely nonprogressive and may resolve spontaneously.
- Iron depletion or overchelation during iron removal therapy can impact renal function.
Conclusions:
- Renal function changes in TM patients are multifactorial, linked to iron overload, chelation therapy, and anemia.
- Management should focus on avoiding excessive iron depletion or overchelation.
- Further prospective studies are crucial to elucidate the natural history and long-term consequences of renal changes in TM.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
